• Joshua Nealon, Alain Bouckenooghe, Margarita Cortes, Laurent Coudeville, Carina Frago, Denis Macina, and Clarence C Tam.
• Sanofi Pasteur Vaccines Epidemiology and Modeling, Lyon, France.
• J. Infect. Dis. 2020 Mar 25.

AbstractDengue endemicity varies but comparative, multi-country data are extremely limited. An improved understanding is needed to prioritize prevention, including vaccination, which is currently recommended only under specific epidemiological conditions. We used serological study data from 46 geographical sites in 13 countries to estimate dengue force of infection (FOI, the proportion of children seroconverting per year) under assumptions of either age-constant or age-varying FOI, and the age at which 50% and 80% of children had been infected. After exclusions, 13,661 subjects were included. Estimated constant FOI varied widely, from 1.7% (Singapore) to 24.1% (the Philippines). In the site-level analysis 44 sites (96%) reached 50% seroconversion, and 35 sites (75%) reached 80% seroconversion, by age 18, with significant heterogeneity. These findings confirm that children living in dengue-endemic countries receive intense early dengue exposure, increasing risk of secondary infection, and imply serosurveys at fine spatial resolutions are needed to inform vaccination campaigns.© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.

6 keywords...

hide…